why choose us

First received: August 15, 2023

Clinical Trial: A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Oligometastatic Renal Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)

Brief Summary: To learn if adding 1 year of therapy with pembrolizumab can help to continue to control RCC after radiation therapy.

Read more